|
1
|
Akao Y, Nakagawa Y, Kitade Y, Kinoshita T
and Naoe T: Downregulation of microRNAs-143 and -145 in B-cell
malignancies. Cancer Sci. 98:1914–1920. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
3
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C,
et al: Human papillomavirus and survival of patients with
oropharyngeal cancer. N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stransky N, Egloff AM, Tward AD, Kostic
AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C,
McKenna A, et al: The mutational landscape of head and neck
squamous cell carcinoma. Science. 333:1157–1160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cancer Genome Atlas Network: Comprehensive
genomic characterization of head and neck squamous cell carcinomas.
Nature. 517:576–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cancer Genome Atlas Research Network:
Comprehensive molecular characterization of clear cell renal cell
carcinoma. Nature. 499:43–49. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miller DL, Puricelli MD and Stack MS:
Virology and molecular pathogenesis of HPV (human
papillomavirus)-associated oropharyngeal squamous cell carcinoma.
Biochem J. 443:339–353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Funk JO, Waga S, Harry JB, Espling E,
Stillman B and Galloway DA: Inhibition of CDK activity and
PCNA-dependent DNA replication by p21 is blocked by interaction
with the HPV-16 E7 oncoprotein. Genes Dev. 11:2090–2100. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kehmeier E, Rühl H, Voland B, Stöppler MC,
Androphy E and Stöppler H: Cellular steady-state levels of 'high
risk' but not 'low risk' human papillomavirus (HPV) E6 proteins are
increased by inhibition of proteasome-dependent degradation
independent of their p53- and E6AP-binding capabilities. Virology.
299:72–87. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gillison ML, D'Souza G, Westra W, Sugar E,
Xiao W, Begum S and Viscidi R: Distinct risk factor profiles for
human papillomavirus type 16-positive and human papillomavirus type
16-negative head and neck cancers. J Natl Cancer Inst. 100:407–420.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chaturvedi AK, Engels EA, Pfeiffer RM,
Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M,
Cozen W, et al: Human papillomavirus and rising oropharyngeal
cancer incidence in the United States. J Clin Oncol. 29:4294–4301.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Karim R, Tummers B, Meyers C, Biryukov JL,
Alam S, Backendorf C, Jha V, Offringa R, van Ommen GJ, Melief CJ,
et al: Human papillomavirus (HPV) upregulates the cellular
deubiquitinase UCHL1 to suppress the keratinocyte's innate immune
response. PLoS Pathog. 9:e10033842013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hashibe M, Brennan P, Benhamou S,
Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova
E, Fernandez L, et al: Alcohol drinking in never users of tobacco,
cigarette smoking in never drinkers, and the risk of head and neck
cancer: Pooled analysis in the International Head and Neck Cancer
Epidemiology Consortium. J Natl Cancer Inst. 99:777–789. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mork J, Lie AK, Glattre E, Hallmans G,
Jellum E, Koskela P, Møller B, Pukkala E, Schiller JT, Youngman L,
et al: Human papillomavirus infection as a risk factor for
squamous-cell carcinoma of the head and neck. N Engl J Med.
344:1125–1131. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
de Villiers EM, Fauquet C, Broker TR,
Bernard HU and zur Hausen H: Classification of papillomaviruses.
Virology. 324:17–27. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Muñoz N, Bosch FX, de Sanjosé S, Herrero
R, Castellsagué X, Shah KV, Snijders PJ and Meijer CJ;
International Agency for Research on Cancer Multicenter Cervical
Cancer Study Group: Epidemiologic classification of human
papillomavirus types associated with cervical cancer. N Engl J Med.
348:518–527. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Phelps WC, Barnes JA and Lobe DC:
Molecular targets for human papillomaviruses: Prospects for
antiviral therapy. Antivir Chem Chemother. 9:359–377. 1998.
View Article : Google Scholar
|
|
18
|
Sandhu SK, Volinia S, Costinean S, Galasso
M, Neinast R, Santhanam R, Parthun MR, Perrotti D, Marcucci G,
Garzon R, et al: miR-155 targets histone deacetylase 4 (HDAC4) and
impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the
Eµ-miR-155 transgenic mouse model. Proc Natl Acad Sci USA.
109:20047–20052. 2012. View Article : Google Scholar
|
|
19
|
Lenze D, Leoncini L, Hummel M, Volinia S,
Liu CG, Amato T, De Falco G, Githanga J, Horn H, Nyagol J, et al:
The different epidemiologic subtypes of Burkitt lymphoma share a
homogenous micro RNA profile distinct from diffuse large B-cell
lymphoma. Leukemia. 25:1869–1876. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lajer CB, Nielsen FC, Friis-Hansen L,
Norrild B, Borup R, Garnæs E, Rossing M, Specht L, Therkildsen MH,
Nauntofte B, et al: Different miRNA signatures of oral and
pharyngeal squamous cell carcinomas: A prospective translational
study. Br J Cancer. 104:830–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lace MJ, Anson JR, Klingelhutz AJ, Lee JH,
Bossler AD, Haugen TH and Turek LP: Human papillomavirus (HPV) type
18 induces extended growth in primary human cervical, tonsillar, or
foreskin keratinocytes more effectively than other high-risk
mucosal HPVs. J Virol. 83:11784–11794. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rahimy E, Kuo SZ and Ongkeko WM:
Evaluation of non-coding RNAs as potential targets in head and neck
squamous cell carcinoma cancer stem cells. Curr Drug Targets.
15:1247–1260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li M, Liu L, Zang W, Wang Y, Du Y, Chen X,
Li P, Li J and Zhao G: miR-365 overexpression promotes cell
proliferation and invasion by targeting ADAMTS-1 in breast cancer.
Int J Oncol. 47:296–302. 2015.PubMed/NCBI
|
|
24
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Walter V, Yin X, Wilkerson MD, Cabanski
CR, Zhao N, Du Y, Ang MK, Hayward MC, Salazar AH, Hoadley KA, et
al: Molecular subtypes in head and neck cancer exhibit distinct
patterns of chromosomal gain and loss of canonical cancer genes.
PLoS One. 8:e568232013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lajer CB and von Buchwald C: The role of
human papillomavirus in head and neck cancer. APMIS. 118:510–519.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Scheffner M, Huibregtse JM, Vierstra RD
and Howley PM: The HPV-16 E6 and E6-AP complex functions as a
ubiquitin-protein ligase in the ubiquitination of p53. Cell.
75:495–505. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fakhry C, Westra WH, Li S, Cmelak A, Ridge
JA, Pinto H, Forastiere A and Gillison ML: Improved survival of
patients with human papillomavirus-positive head and neck squamous
cell carcinoma in a prospective clinical trial. J Natl Cancer Inst.
100:261–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Flores ER, Allen-Hoffmann BL, Lee D and
Lambert PF: The human papillomavirus type 16 E7 oncogene is
required for the productive stage of the viral life cycle. J Virol.
74:6622–6631. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
O'Rorke MA, Ellison MV, Murray LJ, Moran
M, James J and Anderson LA: Human papillomavirus related head and
neck cancer survival: A systematic review and meta-analysis. Oral
Oncol. 48:1191–1201. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wald AI, Hoskins EE, Wells SI, Ferris RL
and Khan SA: Alteration of microRNA profiles in squamous cell
carcinoma of the head and neck cell lines by human papillomavirus.
Head Neck. 33:504–512. 2011. View Article : Google Scholar :
|
|
32
|
Lajer CB, Garnæs E, Friis-Hansen L,
Norrild B, Therkildsen MH, Glud M, Rossing M, Lajer H, Svane D,
Skotte L, et al: The role of miRNAs in human papilloma virus
(HPV)-associated cancers: Bridging between HPV-related head and
neck cancer and cervical cancer. Br J Cancer. 106:1526–1534. 2012.
View Article : Google Scholar : PubMed/NCBI
|
